The genes encoding the inner core protein VP6 of African horsesickness virus (AHSV) serotypes 3 and 6 have been cloned and sequenced. The genes are 1169 nucleotides in length and both encode a largely hydrophilic protein of 369 amino acids. The VP6 amino acid sequence is highly conserved between the two serotypes with an overall similarity of 95%. Comparison of the AHSV VP6 amino acid sequences with those of bluetongue virus serotype 10 VP6 revealed that it is 41 amino acids longer with an overall amino acid identity of 29%. The similarity is mainly confined to a short but highly conserved 13 amino acid region at the N terminus, a short seven amino acid region at the C terminus and a 22 amino acid region close to the C terminus. Within this last region is a smaller 11 amino acid region from 318 to 328 with a 91% similarity to the Rep helicase of Escherichio coil.
African horsesickness virus (AHSV) belongs to the genus Orbivirus in the family Reoviridae. The prototype species of the genus is bluetongue virus (BTV). All orbiviruses have a segmented dsRNA genome and each of the 10 segments encodes at least one virus polypeptide (Huismans, 1979) . Amongst the capsid proteins four major and three minor structural proteins can be distinguished (Verwoerd et al., 1972) of which VP1, VP4 and VP6 are minor inner core proteins.
The core particles are associated with an RNA-dependent RNA polymerase activity. This enables the virus to synthesize mRNA from the virion dsRNA templates, VP1 is the prime candidate for the RNA polymerase. VP4 is thought to be responsible for the guanylyl transferase activity, based on results indicating that VP4 of BTV binds GTP (Le Blois et aI., 1992) . The VP6 protein of BTV, encoded by segment 9 Author for correspondence: H, Huismans, Fax +27 12 3424058. e-mail HenkH@scientia,up.ac.za The nucleotide sequence data reported here have been submitted to the GenBank sequence database and assigned the accession numbers U191881 (AHSV-3 segment 9) and U33000 (AHSV-6 segment 9). (Mertens et al., 1984) , is reported to possess ss-and dsRNAbinding properties (Roy et aL, 1990) and sequence analysis has revealed a motif common to several helicases (Roy, 1992) . Such an activity may be involved in unwinding the dsRNA prior to transcription and replication. VP6 may also have a role in encapsidation of the RNA (Roy, 1992) . Hayama & Li (1994) reported sequence and amino acid similarity to several known methylases. The BTV VP6 amino acid sequence is highly conserved in all serotypes (Roy et al., 1990; Hwang et al., 1992) .
Very little is known about the three minor structural proteins of AHSV, especially VP6; the gene has not been cloned and no sequence data on the protein are available. The sequence similarity between the structural proteins of BTV and AHSV is generally quite low; it is therefore of interest to determine if the helicase and methylase motifs on the protein are conserved between the two viruses.
A major factor in the delay in characterizing VP6 in our laboratory has been an unexpected difficulty in cloning the fullsized VP6 gene of AHSV, In a typical cloning experiment with equal amounts of the purified AHSV-3 dsRNA segments, using the cloning method of Cashdollar (1982) with the modifications described by Bremer et al. (1990) , less than 2% of the clones were VP6-specific and none of these were full-length. The same cDNA library might contain as many as 20 or more fullsized VP7 or NS2 clones, which are approximately the same length. From one such cloning experiment, two partial clones of the VP6 gene of AHSV-3, 740 bp and 931 bp, containing the 5' and 3' termini of the gene, respectively, were obtained. Restriction enzyme mapping revealed an overlap around a BgllI site which was then exploited to construct a full-sized copy of the gene. The constructed gene was fully sequenced with the dideoxynucleotide chain termination method (Sanger et al., 1977) using a Sequenase 2.0 kit (USB). The gene was then modified by PCR (Nel & Huismans, I991) in order to remove the 5' and 3' GC tails added as part of the cloning strategy. BamHI sites were added to facilitate cloning into expression vectors. The primer sequences were as follows: forward primer: VP6.1 5' CAGGGATCCGTTAAATAAGT TGTCTCATGTC 3'; reverse primer: VP6.2 5' CAGGGA TCCGTAAGTTTTAAGTTGCCCTC 3'. The amplified gene was recloned in the Bluescribe expression vector pBS (Stratagene) and again sequenced to confirm that no errors were Fig. 1 . Comparison of the amino acid sequences of VP6 of AHSV-6 and AHSV-3 to that of BI-V-10 VP6 (Fukusho et at., 1989) . A region of high sequence identity that contains a conserved helicase motif is underlined. Data were obtained from protein similarity alignments performed on Microgenie (Queen & Korn, 1984) .
introduced by PCR. The same primers were subsequently used to amplify the gene from a cDNA preparation of AHSV-6 after partial sequence analysis indicated that the areas of the noncoding region incorporated in the primers were fully conserved between the two serotypes. The gene was successfully amplified and cloned in pBS and pUC mplg-derived M13 (Sambrook et al., 1989) . The gene was sequenced using several oligonucleotide primers complementary to internal regions of the gene. The VP6 genes of both serotypes were 1169 nucleotides in length with a 1107 nucleotide open reading frame, encoding a peptide of 369 amino acids. The 5' and 3' non-coding regions were 18 and 41 nucleotides respectively. The nucleotide sequences of the two serotypes were highly conserved, with 97% identity. The conserved sequences GTTAAA at the 5' end and ACTTAC at the 3' end were present (Mertens & Sangar, 1985; Roy, 1989) . A comparison of the amino acid sequences of VP6 of AHSV-6, AHSV-3 and BTV-10 (Fukusho et al., 1989) is shown in Fig. 1 . Similar to BTV VP6, which show up to 99 % similarity between different serotypes (Hwang et al., 1992) , AHSV VP6 amino acid sequences were highly conserved, with an overall similarity of 95 % and 100% identity in the last 128 amino acids. This is a higher level of conservation than the 76% idefltity and 85 % similarity found between the amino acid sequences of the non-structural protein NS3 of AHSV-3 and AHSV-9 (Van Staden & Huismans, 1991 iiiiiiiiiiiiiiiiiii# ! iiii ji i{ {ijiiljiiljijiljililij similarity of 43 % and 29 % amino acid identity. VP6 appears to be highly conserved within a serogroup; it is therefore surprising that inter-serogroup conservation was not higher. There were three regions that were highly conserved between the VP6 proteins of the two viruses. There was a 100% similarity (76% identity) in the first 13 amino acids of the N terminus and the last seven amino acids at the C terminus also show 100 % similarity. There was a 22 amino acid region close to the C terminus (underlined in Fig. 1 ) that showed 77% identity with several serotypes of BTV. Within this region was an 11 amino acid sequence from positions 318 to 328 that had 91% similarity to the Rep helicase of Escherichia coil This has also been described by Roy (1992) and Hayama & Li (1994) for BTV VP6. No similarity to any known methylase was found. Some other interesting characteristics are that the glycine content was very high (16"3 %), which was even higher than in the case of BTV VP6 (12%). As with BTV, several glycine residues were located close to the N terminus, from 93-111 and 118-133. The number of charged amino acids was also high, but still only 82 % of the level reported for BTV VP6 (Roy, 1989) . It would be interesting to determine if this difference affects nudeic acid binding ability.
Hydrophilicity plots of the VP6 proteins of AHSV-3 and BTV-10 were determined according to the method of Kyte & Doolittle (1982) and plotted on ANTHEPROT (Del6age et al., 1988) . Both the VP6 proteins were predominantly hydrophilic and particularly so in the first 75 amino acid region, where the patterns are very similar. Segment 9 of both AHSV serotypes has been cloned into the in vitro expression vector pBS and the Bac-to-Bac (Life Technologies; Luckow et al., 1993) pFASTBAC1 expression vector for in vivo expression. SDS-PAGE analysis of VP6 expression, both in vitro and in vivo, revealed a difference in electrophoretic mobility. AHSV-6 VP6 runs just below the 46 kDa marker while AHSV-3 VP6 runs between 46 kDa and the predicted molecular mass of 38 kDa (Microgenie, Queen & Kom, 1984; ANTHEPROT, Ddleage et al., 1988) . This may indicate a conformation difference as both proteins have the same number of amino acids. The identity of the proteins was confirmed by Western immunoblot analysis utilizing guinea pig anti-AHSV-3 serum obtained from the Onderstepoort Veterinary Institute (South Africa). The amounts of AHSV VP6 produced are sufficient to proceed with the characterization of its function. This study was funded by the Foundation for Research Development.
